Implications of coronary artery calcium testing on risk stratification for lipid-lowering therapy according to the 2016 European Society of Cardiology recommendations: The MESA study (2018)
- Authors:
- Autor USP: BITTENCOURT, MÁRCIO SOMMER - HU
- Unidade: HU
- DOI: 10.1177/2047487318788930
- Subjects: DOENÇAS CARDIOVASCULARES; PREVENÇÃO PRIMÁRIA; VASOS CORONÁRIOS; CÁLCIO
- Language: Inglês
- Imprenta:
- Source:
- Título: European Journal of Preventive Cardiology
- ISSN: 2047-4873
- Volume/Número/Paginação/Ano: v. 25, n. 17, p. 1887-1898, 2018
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
BITTENCOURT, Márcio Sommer et al. Implications of coronary artery calcium testing on risk stratification for lipid-lowering therapy according to the 2016 European Society of Cardiology recommendations: The MESA study. European Journal of Preventive Cardiology, v. 25, n. 17, p. 1887-1898, 2018Tradução . . Disponível em: https://doi.org/10.1177/2047487318788930. Acesso em: 09 fev. 2026. -
APA
Bittencourt, M. S., Blankstein, R., Blaha, M. J., Sandfort, V., Agatston, A. S., Budoff, M. J., et al. (2018). Implications of coronary artery calcium testing on risk stratification for lipid-lowering therapy according to the 2016 European Society of Cardiology recommendations: The MESA study. European Journal of Preventive Cardiology, 25( 17), 1887-1898. doi:10.1177/2047487318788930 -
NLM
Bittencourt MS, Blankstein R, Blaha MJ, Sandfort V, Agatston AS, Budoff MJ, Blumenthal RS, Krumholz HM, Nasir K. Implications of coronary artery calcium testing on risk stratification for lipid-lowering therapy according to the 2016 European Society of Cardiology recommendations: The MESA study [Internet]. European Journal of Preventive Cardiology. 2018 ; 25( 17): 1887-1898.[citado 2026 fev. 09 ] Available from: https://doi.org/10.1177/2047487318788930 -
Vancouver
Bittencourt MS, Blankstein R, Blaha MJ, Sandfort V, Agatston AS, Budoff MJ, Blumenthal RS, Krumholz HM, Nasir K. Implications of coronary artery calcium testing on risk stratification for lipid-lowering therapy according to the 2016 European Society of Cardiology recommendations: The MESA study [Internet]. European Journal of Preventive Cardiology. 2018 ; 25( 17): 1887-1898.[citado 2026 fev. 09 ] Available from: https://doi.org/10.1177/2047487318788930 - Heart disease and stroke statistics-2019 update: a report From the American Heart Association
- The yield of downstream tests after exercise treadmill testing: a prospective cohort study
- Statin Eligibility in Primary Prevention: From a Risk-Based Strategy to a Personalized Approach Based on the Predicted Benefit
- Coronary calcium score vs. computed tomography angiography as tools to stratify cardiovascular risk
- Statin eligibility in primary prevention: from a risk-based strategy to a personalized approach based on the predicted benefit
- Impact of coronary remodeling on fractional flow reserve [letter]
- Percent reduction or target-based strategies to manage blood cholesterol in subjects at intermediate risk: cardiovascular benefit versus diabetes onset risk in real world patients
- Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis)
- Anomalous origin of the coronary artery arising from the opposite sinus: prevalence and outcomes in patients undergoing coronary CTA
- Multimodality imaging of an adult with Shone complex
Informações sobre o DOI: 10.1177/2047487318788930 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
